- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02185235
A Randomized Controlled Trial of Electrical Stimulation to Treat Pelvic Floor Disorder
To Evaluate The Efficacy of Electrical Stimulation and Biofeedback Treatment for Pelvic Floor Disorder Women
Female pelvic floor disorders (PFDs) include urinary incontinence,pelvic organ prolapse (POP), and fecal incontinence-which often occur together.
Pelvic floor disorders impair multiple aspects of the life quality, including the sexual function of women.
Surgery became the first choice of treatment, however, and not until 1980s was the renewed interest in conservative therapies.
This may be because of higher awareness among women and cost of and morbidity after surgery.
The conservative treatment included pelvic floor muscle training, electrical stimulation, vaginal cones, and biofeedback.
The outcome was up to 35~70 % improved rate as the literature before. Current guidelines recommended conservative management as a first-line therapy. However, there was no consistent consensus on this issue due to variations in stimulation parameters、adjuvant concurrent modality or duration of treatment course, and insufficient result about large and long term follow up of randomized- controlled studies.
Therefore, the investigators try to conduct one randomized-controlled trial to evaluate the efficacy of conservative treatment for Pelvic floor disorder (Pelvic organ prolapse, urinary incontinence, chronic pelvic pain etc.).
At the aspect of Quality of life, our studies tried to focus on the different domains of pelvic disorder and sexual quality by means of validated questionnaire more objectively.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tsung-Hsien Su, PhD
- Phone Number: 2544 886-25433535
- Email: drthsu@mail.itrip.com.tw
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- Taiwan, Taipei, Mackay Memorial hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients suffering from pelvic organ prolapse and/or urinary incontinence and/or fecal incontinence.
Exclusion Criteria:
- Patient is pregnant The patient had any major medical or psychiatric disease The patient with Metabolic medical device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Biofeedback & Electrical Stimulation
Twice a week, 20 minutes for each time.
One course includes 18 times treatment.
|
The Chartered Society of Physiotherapy recommends the following standard for electrical devices. Frequency: 35 Hertz. Pulse width: 250µs (0.25ms). Current type: bi-phasic rectangular. Intensity: maximum tolerated. Duty-cycle: 5 seconds on/10 seconds off. Very weak muscles: 5 seconds on/15 seconds off. Treatment time: 5 minutes initially, gradually increasing to 20 minutes.
Other Names:
Biofeedback is a treatment technique in which people are trained to improve their health by using signals from their own bodies
Other Names:
|
|
Active Comparator: Biofeedback & Pelvic Floor Training
Pelvic floor training every 20 minutes for each time, twice a week.
and total for 18 times.
|
Biofeedback is a treatment technique in which people are trained to improve their health by using signals from their own bodies
Other Names:
First, as you are sitting or lying down, try to contract the muscles you would use to stop urinating To contract the pelvic muscles, squeeze for 3 seconds and then relax for 3 seconds. Repeat this exercise to 20 minutes each session. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1-Hour Pad test of urine leakage amount (gm)
Time Frame: Total 18 times of treatment, for 3 months
|
A pad test is a tool to used to measure urine leakage amount . Pad testing can be done over a period of time to one hour. A sanitary napkin is weighed and then worn for sixty minutes, during which time the individual is asked to perform certain activities which may include:
|
Total 18 times of treatment, for 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life (score)
Time Frame: Total 18 times of treatment, for 3 months
|
Total 18 times of treatment, for 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vaginal pressure (mmHg)
Time Frame: Total 18 times of treatment, for 3 months
|
Use the vaginal probe sensor to evaluate the objective level of vaginal squeezing pressure and endurance time
|
Total 18 times of treatment, for 3 months
|
|
Urodynamics data analysis
Time Frame: Total 18 times of treatment, for 3 months
|
Use urodyanmic examinations for evaluation of bladder function
|
Total 18 times of treatment, for 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: TSUNG H Su, Professor, Mackay Memorial Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14MMHIS031
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse, Patient Education | Pelvic Organ Prolapse (POP)United States
-
Hillel Yaffe Medical CenterCompletedHysterectomy | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse (POP)Israel
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Wolfson Medical CenterRecruiting
-
Queen's UniversityNot yet recruitingPelvic Organ Prolapse (POP)Canada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
Chung Shan Medical UniversityActive, not recruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Sacrocolpopexy | PectopexyTaiwan
-
A.M.I. Agency for Medical Innovations GmbHActive, not recruitingProlapse | Pelvic Organ Prolapse (POP) | SacrocolpopexyGermany
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
Clinical Trials on Electrical Stimulation
-
National Yang Ming UniversityCompleted
-
Baylor College of MedicineAvazzia, IncCompletedCOVID-19 | Muscle Weakness | Muscle AtrophyUnited States
-
Baylor College of MedicineAvazzia, IncCompletedCovid19 | Muscle Weakness | Muscle AtrophyUnited States
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Baylor College of MedicineAvazzia, IncCompletedDiabetes | Peripheral Arterial Disease | Diabetic Foot Ulcer | Peripheral NeuropathyUnited States
-
University of FloridaCompletedHemiplegia | Cerebrovascular AccidentUnited States
-
University of Sao PauloSuspendedRehabilitation | Critical CareBrazil
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...Completed
-
Zhihong LUNot yet recruitingHypotension | Anesthesia
-
Harran UniversityCompleted